fda glp-1 enforcement news october 2025 restricts non-approved compounded weight loss products Beyond the Headlines: FDA Warning

7080 = very high risk 6070 = high risk 4060 = moderate below 40 = lower risk West Virginia ranks as the most at-risk state in the U.S., with the highest Awareness Gap Index score

Recruitment is complex because participants must meet: specific BMI thresholds comorbidity criteria lifestyle intervention protocols But there is another factor that complicates trial execution: the geography of obesity itself

Building Sustainable Habits for Long-Term Success GLP-1 medications are most effective when paired with sustainable habits

Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors

Several studies have primarily evaluated the changes in cardiovascular risk biomarkers upon the use of GLP-1 RAs